This inventor holds 1 USPTO granted patent. Top assignees: Digna Biotech, S.l., Proyecto Biomedicine Cima, S.l.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 4 
1 out of 1 Years Active: 2012
Title: Javier Dotor Herrerías: Innovator in Peptide Technology
Introduction
Javier Dotor Herrerías is a notable inventor based in Pamplona, Spain. He has made significant contributions to the field of biotechnology, particularly in the development of peptides that have the potential to inhibit the biological activity of transforming growth factor beta 1 (TGF-β1). His work is crucial for addressing various diseases associated with excessive TGF-β1 expression.
Latest Patents
Javier holds a patent for peptides with the capacity to bind to transforming growth factor β1 (TGF-β1). These peptides are designed to inhibit the biological activity of TGF-β1 through direct binding. This innovation has potential applications in treating conditions such as liver fibrosis, pulmonary fibrosis, and corneal fibrosis.
Career Highlights
Throughout his career, Javier has worked with various organizations, including Proyecto Biomedicine Cima, S.L. and Digna Biotech, S.L. His expertise in peptide technology has positioned him as a key figure in the biotechnology sector.
Collaborations
Javier has collaborated with notable professionals in his field, including Francisco Borrás Cuesta and Esperanza Feijoo Blanco. These collaborations have further enhanced his research and development efforts.
Conclusion
Javier Dotor Herrerías is a pioneering inventor whose work in peptide technology holds promise for advancing treatments for diseases linked to TGF-β1. His contributions to biotechnology continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile